C M Bidwell & Associates LTD Incyte Corp Transaction History

C M Bidwell & Associates LTD

  • $162 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$57.77 - $65.93 $97,920 - $111,751
1,695 New
1,695 $97,000
Q4 2019

Feb 12, 2020
SELL
$73.04 - $95.72 $343,288 - $449,884
-4,700 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$72.82 - $86.52 $342,253 - $406,644
4,700 New
4,700 $349,000

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email